| Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses A Artese, V Svicher, G Costa, R Salpini, VC Di Maio, M Alkhatib, ... Drug Resistance Updates, 100721, 2020 | 99 | 2020 |
| SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 M Alkhatib, V Svicher, R Salpini, FA Ambrosio, MC Bellocchi, L Carioti, ... Microbiology spectrum 9 (3), e01096-21, 2021 | 52 | 2021 |
| Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile M Alkhatib, R Salpini, L Carioti, FA Ambrosio, S D’Anna, L Duca, G Costa, ... Microbiology spectrum 10 (2), e02732-21, 2022 | 50 | 2022 |
| Molecular accounting and profiling of human respiratory microbial communities: toward precision medicine by targeting the respiratory microbiome for disease diagnosis and treatment AR Alsayed, A Abed, HA Khader, LMH Al-Shdifat, L Hasoun, ... International Journal of Molecular Sciences 24 (4), 4086, 2023 | 19 | 2023 |
| Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control R Salpini, M Alkhatib, G Costa, L Piermatteo, FA Ambrosio, VC Di Maio, ... Journal of Antimicrobial Chemotherapy 76 (2), 396-412, 2021 | 17 | 2021 |
| Asthma-COPD overlap in clinical practice (ACO_CP 2023): toward precision medicine AR Alsayed, MS Abu-Samak, M Alkhatib Journal of Personalized Medicine 13 (4), 677, 2023 | 15 | 2023 |
| A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients AR Alsayed, A Al-Dulaimi, M Alkhatib, M Al Maqbali, MAA Al-Najjar, ... Expert Review of Respiratory Medicine 16 (11-12), 1167-1190, 2022 | 15 | 2022 |
| First case of a COVID-19 patient infected by delta AY. 4 with a rare deletion leading to a N gene target failure by a specific real time PCR assay: Novel omicron VOC might be … M Alkhatib, MC Bellocchi, G Marchegiani, S Grelli, V Micheli, D Stella, ... Microorganisms 10 (2), 268, 2022 | 15 | 2022 |
| The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N … R Salpini, M Surdo, MF Cortese, GA Palumbo, L Carioti, G Cappiello, ... Clinical Microbiology and Infection 25 (7), 906. e1-906. e7, 2019 | 15 | 2019 |
| Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment L Piermatteo, R Scutari, R Chirichiello, M Alkhatib, V Malagnino, A Bertoli, ... Methods 201, 74-81, 2022 | 14 | 2022 |
| New markers in monitoring the reactivation of hepatitis B virus infection in immunocompromised hosts V Svicher, R Salpini, V Malagnino, L Piermatteo, M Alkhatib, C Cerva, ... Viruses 11 (9), 783, 2019 | 14 | 2019 |
| Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study A Borghetti, M Alkhatib, A Dusina, L Duca, V Borghi, M Zazzi, ... Journal of Antimicrobial Chemotherapy 77 (3), 740-746, 2022 | 9 | 2022 |
| Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/HBsag-negative patients with HIV infection by highly sensitive molecular assays, and can be … R Salpini, V Malagnino, L Piermatteo, T Mulas, M Alkhatib, R Scutari, ... Microorganisms 8 (11), 1819, 2020 | 9 | 2020 |
| Targeting SARS-CoV-2 nsp13 helicase and assessment of druggability pockets: identification of two potent inhibitors by a multi-site in silico drug repurposing approach I Romeo, FA Ambrosio, G Costa, A Corona, M Alkhatib, R Salpini, ... Molecules 27 (21), 7522, 2022 | 7 | 2022 |
| Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and … L Piermatteo, S D’Anna, A Bertoli, M Bellocchi, L Carioti, L Fabeni, ... Emerging Microbes & Infections 12 (1), 2219347, 2023 | 6 | 2023 |
| Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach FA Ambrosio, G Costa, I Romeo, F Esposito, M Alkhatib, R Salpini, ... Journal of Chemical Information and Modeling 63 (11), 3601-3613, 2023 | 6 | 2023 |
| SARS-CoV-2 mutations and variants may muddle the sensitivity of COVID-19 diagnostic assays M Alkhatib, L Carioti, S D’Anna, F Ceccherini-Silberstein, V Svicher, ... Microorganisms 10 (8), 1559, 2022 | 6 | 2022 |
| Establishment of a seronegative occult infection with an active hepatitis B virus reservoir enriched of vaccine escape mutations in a vaccinated infant after liver transplantation R Salpini, A Pietrobattista, L Piermatteo, MS Basso, MC Bellocchi, ... The Journal of Infectious Diseases 220 (12), 1935-1939, 2019 | 6 | 2019 |
| Highly sensitive HBsAg, anti-HBc and anti HBsAg titres in early diagnosis of HBV reactivation in anti-HBc-positive onco-haematological patients C Cerva, R Salpini, M Alkhatib, V Malagnino, L Piermatteo, A Battisti, ... Biomedicines 10 (2), 443, 2022 | 4 | 2022 |
| HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of … L Piermatteo, M Alkhatib, S D’anna, V Malagnino, A Bertoli, E Andreassi, ... Biomedicines 9 (10), 1352, 2021 | 3 | 2021 |
